Welage LS - Search Results

1

The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.

Stout SM, Nielsen J, Bleske BE, Shea M, Brook R, Kerber K, Welage LS. Stout SM, et al. Among authors: welage ls. J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):373-9. doi: 10.1177/1074248410372926. Epub 2010 Aug 12. J Cardiovasc Pharmacol Ther. 2010. PMID: 20705902 Free PMC article. Clinical Trial.

2

Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine.

Stout SM, Nielsen J, Welage LS, Shea M, Brook R, Kerber K, Bleske BE. Stout SM, et al. Among authors: welage ls. J Clin Pharmacol. 2011 Mar;51(3):389-96. doi: 10.1177/0091270010365559. Epub 2010 Apr 16. J Clin Pharmacol. 2011. PMID: 20400652 Free PMC article. Clinical Trial.

3

The effect of dosage release formulations on the pharmacokinetics of propranolol stereoisomers in humans.

Bleske BE, Welage LS, Rose S, Amidon GL, Shea MJ. Bleske BE, et al. Among authors: welage ls. J Clin Pharmacol. 1995 Apr;35(4):374-8. doi: 10.1002/j.1552-4604.1995.tb04076.x. J Clin Pharmacol. 1995. PMID: 7650226 Free article. Clinical Trial.

4

Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure.

Bleske BE, Welage LS, Kramer WG, Nicklas JM. Bleske BE, et al. Among authors: welage ls. J Clin Pharmacol. 1998 Aug;38(8):708-14. doi: 10.1002/j.1552-4604.1998.tb04810.x. J Clin Pharmacol. 1998. PMID: 9725546 Free article. Clinical Trial.

5

Lack of interaction between the peptidomimetic substrates captopril and cephradine.

Foster DR, Yee S, Bleske BE, Carver PL, Shea MJ, Menon SS, Ramachandran C, Welage LS, Amidon GL. Foster DR, et al. Among authors: welage ls. J Clin Pharmacol. 2009 Mar;49(3):360-7. doi: 10.1177/0091270008329554. J Clin Pharmacol. 2009. PMID: 19246733 Free article. Clinical Trial.

6

Cardiovascular risk among university students from developed and developing nations.

Bleske BE, Erickson SR, Fahoum S, Devarakonda KR, Welage LS, Koudmani M, Pantham N, Edwin SB, Devarakonda S, Shea MJ, Martha S, Khalidi N. Bleske BE, et al. Among authors: welage ls. Open Cardiovasc Med J. 2011;5:117-22. doi: 10.2174/1874192401105010117. Epub 2011 May 13. Open Cardiovasc Med J. 2011. PMID: 21673835 Free PMC article.

7

Evaluation of dosage-release formulations on inhibition of drug clearance: effect of sustained- and immediate-release verapamil on propranolol pharmacokinetic parameters.

Bleske BE, Welage LS, Touchette MA, Edwards DJ, Rodman DP, Shea MJ. Bleske BE, et al. Among authors: welage ls. Ther Drug Monit. 1994 Apr;16(2):216-20. doi: 10.1097/00007691-199404000-00019. Ther Drug Monit. 1994. PMID: 8009573 Clinical Trial.

8

Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.

Bleske BE, Welage LS, Warren EW, Brown MB, Shea MJ. Bleske BE, et al. Among authors: welage ls. Pharmacotherapy. 1995 Nov-Dec;15(6):709-12. Pharmacotherapy. 1995. PMID: 8602377

9

Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.

Welage LS, Dunn-Kucharski VA, Berardi RR, Shea MJ, Dechert RE, Bleske BE. Welage LS, et al. Pharmacotherapy. 1995 Mar-Apr;15(2):158-63. Pharmacotherapy. 1995. PMID: 7624262 Free article. Clinical Trial.

10

The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers.

Gin AS, Stringer KA, Welage LS, Wilton JH, Matthews GE. Gin AS, et al. Among authors: welage ls. J Clin Pharmacol. 1989 Aug;29(8):728-32. doi: 10.1002/j.1552-4604.1989.tb03407.x. J Clin Pharmacol. 1989. PMID: 2778093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters